Condition: Non-Hodgkin Lymphoma · B-cell Acute Lymphoblastic Leukemia · Chronic Lymphocytic Leukemia · Sponsor: Imugene Limited
This is a Phase 1/1b, nonrandomized, open-label, parallel assignment, dose-escalation, and dose-expansion study to evaluate the safety and clinical activity of azer-cel, an allogeneic anti-CD19 CAR T, in adults with r/r B ALL, r/r B-cell NHL and CLL/SLL.
This description comes directly from the study's public registry record.
Imugene Clinical Team · +1 984 245 0082 · info@imugene.com
Imugene Clinical Team · +61 2 9423 0881 · info@imugene.com
Always discuss trial participation with your own doctor first.
| Banner MD Anderson Cancer Center | Gilbert, Arizona, United States | Completed |
| City of Hope | Duarte, California, United States | Completed |
| H. Lee Moffitt Cancer Center | Tampa, Florida, United States | Recruiting |
| Winship Cancer Institute Emory University | Atlanta, Georgia, United States | Recruiting |
| Northside Hospital Cancer Institute | Atlanta, Georgia, United States | Recruiting |
| University of Maryland | Baltimore, Maryland, United States | Recruiting |
| Tufts Medical Center | Boston, Massachusetts, United States | Recruiting |
| Dana-Farber Cancer Institute | Boston, Massachusetts, United States | Completed |
| Barbara Ann Karmanos Cancer Institute (Wayne State University) | Detroit, Michigan, United States | Completed |
| University of Minnesota | Minneapolis, Minnesota, United States | Recruiting |
| Weill Cornell Medical College - NY Presbyterian Hospital | New York, New York, United States | Completed |
| Columbia University Irving Medical Center/New York Presbyterian Hospital | New York, New York, United States | Recruiting |
+ 11 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03666000